AbbVie offers a compelling investment opportunity ... and we are excited to have the talented Cerevel team join our organization. Within the Cerevel pipeline, we are very pleased with the positive ...
"Together, AbbVie and Nimble have the potential to help address the significant unmet medical need for people living with autoimmune diseases." "Nimble Therapeutics is committed to transforming ...
AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a preclinical-stage, oral drug for psoriasis. US-based Nimble was set up in ...
A marketing organization structure is how a company arranges its marketing team. It helps decide who does what in marketing and how they work together. Structure helps make sure everyone knows ...
AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs. The new investment will grow its workforce at the site ...
The purchase is just the latest in AbbVie acquisitions this year. AbbVie Inc. said Friday it’s buying Nimble Therapeutics of Madison, Wisconsin, for $200 million. North Chicago-based AbbVie ...
The acquisition of Nimble Therapeutics will grant AbbVie access to a pipeline of oral peptide drugs for the treatment of immune diseases including psoriasis and inflammatory bowel disease AbbVie and ...